Sponsor or institution
Clinical trials and research at Cancer Hospital of Guangxi Medical University
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Cancer Hospital of Guangxi Medical University that are recruiting, in China. By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Combining Sintilimab with Chemoradiotherapy for High-risk Nasopharyngeal Cancer
This study is testing a new treatment plan that combines a cancer drug called Sintilimab with chemotherapy and radiation to see if it helps people with high-risk nasopharyngeal cancer.
-
Using Toripalimab with Chemoradiotherapy for Recurrent Nasopharyngeal Carcinoma
This study is testing if adding a new drug called Toripalimab to standard chemotherapy and radiation can help people with recurrent nasopharyngeal cancer live longer and feel better during treatment.
Quick answers
How many clinical trials run by Cancer Hospital of Guangxi Medical University are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.